Sound Income Strategies, LLC Novartis Ag Transaction History

Sound Income Strategies, LLC

$1.47 Billion
Q4 2024

A detailed history of Sound Income Strategies, LLC transactions in Novartis Ag stock. As of the latest transaction made, Sound Income Strategies, LLC holds 2,196 shares of NVS stock, worth $229,965. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,196

Previous 30 7220.0%

Holding current value

$229,965

Previous $3,000 7000.0%

% of portfolio

0.01%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$96.78 - $117.18 $209,625 - $253,811	2,166 Added 7220.0%	2,196 $213,000
Q3 2024 Oct 10, 2024	SELL	$106.13 - $120.89 $15,601 - $17,770	-147 Reduced 83.05%	30 $3,000
Q1 2024 Apr 15, 2024	BUY	$95.27 - $108.47 $3,429 - $3,904	36 Added 25.53%	177 $17,000
Q4 2023 Jan 10, 2024	BUY	$92.27 - $101.54 $10,241 - $11,270	111 Added 370.0%	141 $14,000
Q2 2023 Jul 10, 2023	SELL	$92.52 - $104.91 $277 - $314	-3 Reduced 9.09%	30 $3,000
Q1 2023 Apr 10, 2023	BUY	$80.03 - $92.81 $2,640 - $3,062	33 New	33 $3,000
Q3 2022 Oct 18, 2022	BUY	$74.61 - $87.26 $746 - $872	10 New	10 $1,000
Q2 2021 Jul 13, 2021	SELL	$85.24 - $94.15 $12,445 - $13,745	-146 Closed	0 $0
Q1 2021 Apr 14, 2021	BUY	$83.5 - $98.47 $835 - $984	10 Added 7.35%	146 $12,000
Q2 2020 Jul 13, 2020	BUY	$80.93 - $91.1 $6,959 - $7,834	86 Added 172.0%	136 $12,000
Q1 2020 Apr 07, 2020	BUY	$70.67 - $99.01 $3,533 - $4,950	50 New	50 $4,000
Q1 2019 Apr 04, 2019	SELL	$75.32 - $86.15 $753 - $861	-10 Closed	0 $0
Q3 2018 Oct 03, 2018	SELL	$66.94 - $77.43 $18,475 - $21,370	-276 Reduced 96.5%	10 $1,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $18,564 - $20,980	286 New	286 $22,000

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.82M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $225B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.

Account

Sound Income Strategies, LLC Novartis Ag Transaction History